Growing evidence has indicated that IL-10 plays a protective role in the damaging heart by mitigating adverse cardiac remodeling in response to pressure overload and angiotensin II stimulation [16,17,36] and that IL-10 activation could become a potential therapeutic in controlling pathological cardiac hypertrophy and preventing HF. This evidence concerns the gene IL10 and hydrops fetalis.